Literature DB >> 23878317

Broadening the repertoire of functional herpes simplex virus type 1-specific CD8+ T cells reduces viral reactivation from latency in sensory ganglia.

Anthony J St Leger1, Sohyun Jeon, Robert L Hendricks.   

Abstract

A large proportion of the world population harbors HSV type 1 (HSV-1) in a latent state in their trigeminal ganglia (TG). TG-resident CD8(+) T cells appear important for preventing HSV-1 reactivation from latency and recurrent herpetic disease. In C57BL/6J mice, half of these cells are specific for an immunodominant epitope on HSV-1 glycoprotein B, whereas the other half are specific for 18 subdominant epitopes. In this study, we show that the CD8(+) T cell dominance hierarchy in the TG established during acute infection is maintained during latency. However, CD8(+) T cells specific for subdominant epitopes lose functionality, whereas those specific for the immunodominant epitope exhibit increased functionality in latently infected TG. Furthermore, we show that IL-10 produced by 16.4 ± 2.8% of TG-resident CD4(+) T cells maintains the immunodominance hierarchy in part through selective inhibition of subdominant CD8(+) T cell proliferation. Upon systemic anti-IL-10R Ab treatment, we observed a significant expansion of functional subdominant CD8(+) T cells, resulting in significantly improved protection from viral reactivation. In fact, systemic anti-IL-10R Ab treatment prevented viral reactivation in up to 50% of treated mice. Our results not only demonstrate that HSV-1 reactivation from latency can be prevented by expanding the repertoire of functional TG-resident CD8(+) T cells, but also that IL-10R blockade might have therapeutic potential to reduce or eliminate recurrent herpetic disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23878317      PMCID: PMC3779892          DOI: 10.4049/jimmunol.1300585

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1.

Authors:  Naveen K Rajasagi; Pradeep B J Reddy; Amol Suryawanshi; Sachin Mulik; Per Gjorstrup; Barry T Rouse
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

2.  CTL response compensation for the loss of an immunodominant class I-restricted HSV-1 determinant.

Authors:  Angus T Stock; Claerwen M Jones; William R Heath; Francis R Carbone
Journal:  Immunol Cell Biol       Date:  2006-09-05       Impact factor: 5.126

3.  Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10.

Authors:  M Daheshia; N Kuklin; S Kanangat; E Manickan; B T Rouse
Journal:  J Immunol       Date:  1997-08-15       Impact factor: 5.422

4.  Interleukin-10 (IL-10) ameliorates corneal disease in a mouse model of recurrent herpetic keratitis.

Authors:  Tammie L Keadle; Patrick M Stuart
Journal:  Microb Pathog       Date:  2004-12-08       Impact factor: 3.738

5.  Ocular safety and efficacy of an HSV-1 gD vaccine during primary and latent infection.

Authors:  A B Nesburn; H Ghiasi; S L Wechsler
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-08       Impact factor: 4.799

6.  Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression.

Authors:  Nicole J Kubat; Robert K Tran; Peterjon McAnany; David C Bloom
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia.

Authors:  Kamal M Khanna; Robert H Bonneau; Paul R Kinchington; Robert L Hendricks
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

Review 8.  Herpes simplex: insights on pathogenesis and possible vaccines.

Authors:  David M Koelle; Lawrence Corey
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

9.  Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes.

Authors:  L A Salvucci; R H Bonneau; S S Tevethia
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.

Authors:  Marika C Kullberg; Dragana Jankovic; Carl G Feng; Sophie Hue; Peter L Gorelick; Brent S McKenzie; Daniel J Cua; Fiona Powrie; Allen W Cheever; Kevin J Maloy; Alan Sher
Journal:  J Exp Med       Date:  2006-10-09       Impact factor: 14.307

View more
  31 in total

Review 1.  Sizing up the key determinants of the CD8(+) T cell response.

Authors:  David C Tscharke; Nathan P Croft; Peter C Doherty; Nicole L La Gruta
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

2.  Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency.

Authors:  Chandra M Menendez; Jeremy K Jinkins; Daniel J J Carr
Journal:  J Immunol       Date:  2016-06-29       Impact factor: 5.422

3.  Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.

Authors:  David J Davido; Eleain M Tu; Hong Wang; Maria Korom; Andreu Gazquez Casals; P Jahnu Reddy; Heba H Mostafa; Benjamin Combs; Steve D Haenchen; Lynda A Morrison
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 4.  Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.

Authors:  Joshua T Schiffer; Sami L Gottlieb
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

5.  HSV-1 clinical isolates with unique in vivo and in vitro phenotypes and insight into genomic differences.

Authors:  Robert J Danaher; Derrick E Fouts; Agnes P Chan; Yongwook Choi; Jessica DePew; Jamison M McCorrison; Karen E Nelson; Chunmei Wang; Craig S Miller
Journal:  J Neurovirol       Date:  2016-10-13       Impact factor: 2.643

Review 6.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

7.  Bolstering the Number and Function of HSV-1-Specific CD8+ Effector Memory T Cells and Tissue-Resident Memory T Cells in Latently Infected Trigeminal Ganglia Reduces Recurrent Ocular Herpes Infection and Disease.

Authors:  Arif A Khan; Ruchi Srivastava; Aziz A Chentoufi; Elizabeth Kritzer; Sravya Chilukuri; Sumit Garg; David C Yu; Hawa Vahed; Lei Huang; Sabrina A Syed; Julie N Furness; Tien T Tran; Nesburn B Anthony; Christine E McLaren; John Sidney; Alessandro Sette; Randolph J Noelle; Lbachir BenMohamed
Journal:  J Immunol       Date:  2017-05-24       Impact factor: 5.422

8.  The Absence of Lymphotoxin-α, a Herpesvirus Entry Mediator (HVEM) Ligand, Affects Herpes Simplex Virus 1 Infection In Vivo Differently than the Absence of Other HVEM Cellular Ligands.

Authors:  Shaohui Wang; Satoshi Hirose; Homayon Ghiasi
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

9.  Distinguishing Features of High- and Low-Dose Vaccine against Ocular HSV-1 Infection Correlates with Recognition of Specific HSV-1-Encoded Proteins.

Authors:  Daniel J J Carr; Grzegorz B Gmyrek; Adrian Filiberti; Amanda N Berube; William P Browne; Brett M Gudgel; Virginie H Sjoelund
Journal:  Immunohorizons       Date:  2020-10-09

10.  Dok-1 and Dok-2 Are Required To Maintain Herpes Simplex Virus 1-Specific CD8+ T Cells in a Murine Model of Ocular Infection.

Authors:  Soumia Lahmidi; Mitra Yousefi; Slimane Dridi; Pascale Duplay; Angela Pearson
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.